Evidence map›Paper›PMID 27514600›Full record

ReviewClinics in chest medicine2016

Hyper-IgE Syndromes and the Lung.

Alexandra F Freeman, Kenneth N Olivier

Abstract readReview
In one paragraph

Review in Clinics in chest medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 83 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Case Report:Frontiers in pediatrics · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Understanding and Managing Hyper IgE Syndromes.ImmunoTargets and therapy · 2025
    Review
  10. Article
  11. Infections in Inborn Errors of STATs.Pathogens (Basel, Switzerland) · 2024
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Alexandra F FreemanLaboratory of Clinical Infectious Diseases, NIAID, NHLBI, National Institutes of Health, Bethesda, MD, USA. Electronic address: freemaal@mail.nih.gov.
Kenneth N OlivierLaboratory of Clinical Infectious Diseases, NIAID, NHLBI, National Institutes of Health, Bethesda, MD, USA.
National Institute of Allergy and Infectious Diseases · US

Funding

Inflammatory and immune dysregulation associated lung diseaseZIAHL006201 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI OLIVIER, KENNETH · 2015 to 2022
$2.1M
Intramural NIH HHS Z99 AI999999
6 · The paper itself

Abstract

Elevated serum IgE has many etiologies including parasitic infection, allergy and asthma, malignancy, and immune dysregulation. The hyper-IgE syndromes caused by mutations in STAT3, DOCK8, and PGM3 are monogenic primary immunodeficiencies associated with high IgE, eczema, and recurrent infections. These primary immunodeficiencies are associated with recurrent pneumonias leading to bronchiectasis; however, each has unique features and genetic diagnosis is essential in guiding therapy, discussing family planning, and defining prognosis. This article discusses the clinical features of these primary immunodeficiencies with a particular focus on the pulmonary manifestations and discussion of the genetics, pathogenesis, and approaches to therapy.

Indexed as

Guanine Nucleotide Exchange FactorsHumansJob SyndromeLung DiseasesMutationPhosphoglucomutaseSTAT3 Transcription FactorDOCK8 protein, humanGuanine Nucleotide Exchange FactorsPGM3 protein, humanPhosphoglucomutaseSTAT3 protein, humanSTAT3 Transcription FactorDOCK8 deficiencyHyper-IgE syndromesJob syndromePGM3 deficiencyPulmonary manifestationsSTAT3

Identifiers

PMID27514600
PMCPMC4987538
OpenAlexW2413119699

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.